Efficacy, Safety and Limitations of Spinal Block for All Infants Under 3 Months
1 other identifier
interventional
90
1 country
1
Brief Summary
Spinal anesthesia (SA) has been shown to be a viable alternative to general anesthesia (GA) for infants and children for a variety of surgical procedures. SA serves to avoid some of the potential risks of GA including the need for airway manipulation, hemodynamic instability, postoperative apnea, and exposure to medications that may cause neurotoxicity .SA allows the prevention and reduction of perioperative complications even if its duration is an important limiting factor. Because of this limitation, short surgery is the most indicated under SA . Premature infants and neurologically impaired children account for the majority of spinal anesthetics used today . This study evaluates the effectiveness, safety and limitations of spinal anesthesia when used for all infants under 3 months undergoing lower abdominal surgery at Ain Shams University Hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedFirst Posted
Study publicly available on registry
March 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 12, 2025
January 1, 2025
3 months
February 21, 2025
March 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
the success rate of spinal block in abdominal surgeries in infants under 3 months of age.
Success rate = (no of total patients - no of all converted general anesthesia patients) divided by no of total cases%.
during the surgery
Secondary Outcomes (5)
Duration of spinal block in minutes
during the surgery
Number of attempts
during the surgery
Depth of insertion of the spinal needle
during the surgery
Blood glucose level
every 30 minutes till end of surgery
Determine the incidence of complications
after spinal block to end of surgery
Study Arms (1)
one arm All Infants Under 3 Months of Age receiving Spinal Block
EXPERIMENTALAll Infants Under 3 Months of Age Scheduled for Lower Abdominal Surgery
Interventions
All patients will receive spinal anesthesia via midline approach with patients in sitting position established by assistant under complete aseptic conditions. A subcutaneous bleb using Lidocaine 1% through the needle of an insulin syringe followed by minor skin scratch to will help avoiding possible intrathecal dermoid implantation . A lumbar puncture will be performed in L4-L5 or L5- S1 interspace using 25-G 25-mm pencil-point spinal needle . Depth of epidural space is anticipated at 0.1 mm/kg . After getting free flow of cerebrospinal fluid (CSF) hyperbaric bupivacaine (0.5%) in a dose of 0.5 mg/kg (0.1 ml/kg) will be slowly injected in the subarachnoid space . The end of the injection will be taken as time zero for further data recording.
Eligibility Criteria
You may qualify if:
- Age under 3 months.
- Physical status: American Society of Anesthesiologists I - II.
- Elective lower abdominal surgeries such as: hernia, hydrocele, undescended testis
You may not qualify if:
- Patient's parents or legal guardian refusing to do this specific procedure.
- Coagulopathy, use of anti-coagulant or antiplatelet therapy.
- Infection at the site of injection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Ain Shams University
Cairo, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
hany mo Elzahaby, prof
Ain Shams University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2025
First Posted
March 12, 2025
Study Start
March 1, 2025
Primary Completion
June 1, 2025
Study Completion
March 1, 2026
Last Updated
March 12, 2025
Record last verified: 2025-01